DSP 1200

Drug Profile

DSP 1200

Alternative Names: DSP-1200

Latest Information Update: 20 May 2016

Price : $50

At a glance

  • Originator Sumitomo Dainippon Pharma
  • Class Antidepressants
  • Mechanism of Action Alpha 2a adrenergic receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 2A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Depressive disorders

Most Recent Events

  • 31 Mar 2016 Phase-I clinical trials in Depressive disorders (Treatment-resistant) in USA (PO) before March 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top